BioGaia (OM:BIOG B) - Cotización, noticias y análisis

Resumen de acción BIOG B

BioGaia AB (publ), empresa del sector sanitario, suministra productos probióticos en todo el mundo.

BIOG B fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	2/6
Financial Health	6/6
Dividends	4/6

Recompensas

El ratio precio-beneficio (34x) es inferior a la media de la industria Biotechs (45x)

Se prevé un crecimiento anual de los beneficios de 8.94%

Análisis de riesgos

El dividendo de 6.03% no está bien cubierto por los flujos de caja

Competidores de BioGaia AB (publ)

Bonesupport Holding

OM:BONEX

kr15.2b

BioArctic

OM:BIOA B

kr17.9b

Swedish Orphan Biovitrum

OM:SOBI

kr97.9b

Biotage

OM:BIOT

kr13.6b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for BioGaia
Historical stock prices
Current Share Price	kr124.80
52 Week High	kr135.60
52 Week Low	kr91.45
Beta	0.55
1 Month Change	8.05%
3 Month Change	5.41%
1 Year Change	22.59%
3 Year Change	54.07%
5 Year Change	34.92%
Change since IPO	1,479.75%

Noticias y actualizaciones recientes

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

Recent updates

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Dec 13

BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Nov 28

Rentabilidad de los accionistas

	BIOG B	SE Biotechs	Mercado SE
7D	9.4%	2.3%	2.8%
1Y	22.6%	0.2%	13.6%

Rentabilidad vs. Industria: BIOG B superó al sector Swedish Biotechs , que obtuvo un rendimiento del -3.2% el año pasado.

Rentabilidad vs. Mercado: BIOG B superó al mercado Swedish, que obtuvo un rendimiento del 11.4% el año pasado.

Volatilidad de los precios

Is BIOG B's price volatile compared to industry and market?
BIOG B volatility
BIOG B Average Weekly Movement	5.7%
Biotechs Industry Average Movement	9.6%
Market Average Movement	6.2%
10% most volatile stocks in SE Market	12.8%
10% least volatile stocks in SE Market	3.6%

Precio estable de las acciones: BIOG B no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de BIOG B (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1990	210	Theresa Agnew	www.biogaia.com

BioGaia AB (publ), empresa del sector sanitario, suministra productos probióticos en todo el mundo. La empresa opera a través de los segmentos de Pediatría, Salud del Adulto y Otros. El segmento pediátrico ofrece gotas, soluciones de rehidratación oral y comprimidos para la salud intestinal, así como cultivos que se utilizan como ingrediente en preparados para lactantes.

Resumen de fundamentos de BioGaia AB (publ)

¿Cómo se comparan los beneficios e ingresos de BioGaia con su capitalización de mercado?
Estadísticas fundamentales de BIOG B
Capitalización bursátil	kr12.60b
Beneficios(TTM)	kr371.25m
Ingresos (TTM)	kr1.30b

33.9x

Ratio precio-beneficio (PE)

9.7x

Ratio precio-ventas (PS)

¿Está BIOG B sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de BIOG B
Ingresos	kr1.30b
Coste de los ingresos	kr346.97m
Beneficio bruto	kr953.51m
Otros gastos	kr582.25m
Beneficios	kr371.25m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

Jul 23, 2024

Beneficios por acción (BPA)	3.68
Margen bruto	73.32%
Margen de beneficio neto	28.55%
Ratio deuda/patrimonio	0%

¿Cómo se ha desempeñado BIOG B a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

5.5%

Rentabilidad actual por dividendo

52%

Ratio de pagos

Resumen de acción BIOG B

Recompensas

Análisis de riesgos

Competidores de BioGaia AB (publ)

OM:BONEX

kr15.2b

OM:BIOA B

kr17.9b

OM:SOBI

kr97.9b

OM:BIOT

kr13.6b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Recent updates

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)